Pauline Bosco-Levy

MD, PhD
Bordeaux PharmacoEpi

Presentation(s):

• OP-1D - Risk of Malignancies in Newly Treated Patients with Disease-modifying Drugs for Multiple Sclerosis: Assessment According to Cohort and Nested-case Control Approaches

  Wednesday, August 25, 2021
  4:30 PM – 6:00 PM US Eastern Time